Thymalin / Thymulin

39,90 

5% off when paying with cryptocurrency

Thymalin 20mg – Thymus-Derived Immune Peptide

  • Synthetic nonapeptide structurally related to the natural thymic hormone thymulin.
  • Zinc-dependent immunomodulatory peptide for T-cell differentiation and thymic function research.
  • Forms essential 1:1 complex with Zn²⁺ for biological activity. Research applications include immunomodulation, hematopoiesis, immunosenescence, and thymus-immune axis studies.
  • Purity ≥99% (HPLC-verified). Supplied as lyophilized powder, 20mg per vial.
  • Store at -20°C. For research purposes only. Not intended for human consumption.
Quantity Price Discount
11-20 33,92  15%
21+ 31,92  20%

Delivery time: 1–6 Working Days

Add 70,00  to cart and get free shipping!

Buy now

Description

Thymalin / Thymulin 20mg Peptide

Chemical diagram for Thymalin by NEUROtiker – Own work, Public Domain, https://commons.wikimedia.org/w/index.php?curid=2231106

KEY SPECIFICATIONS

ParameterSpecification
TypeSynthetic nonapeptide
TargetImmunomodulation, T-cell differentiation
Molecular FormulaC₃₃H₅₄N₁₂O₁₅
Molecular Weight858.9 Da
CAS Number63958-90-7
SequencePyr-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn
Zinc RequirementEssential for biological activity (1:1 Zn²⁺ complex)
FormLyophilized powder
Purity≥99% (HPLC)
Quantity20mg
Storage-20°C

PRODUCT OVERVIEW

Thymalin is a synthetic nonapeptide structurally related to the endogenous thymic hormone thymulin. This immunomodulatory research peptide serves as a tool for investigating T-cell differentiation, hematopoietic stem cell mechanisms, and thymic-mediated immune regulation.

A defining characteristic is its absolute zinc dependency—thymalin requires 1:1 Zn²⁺ complex formation for biological activity, creating a direct link between trace element status and immune function in experimental models. BIONIX supplies Thymalin with ≥99% purity and complete analytical verification for controlled laboratory research.

MECHANISM OF ACTION

Thymalin operates through thymic hormone pathways, modulating T-cell development and immune system homeostasis. The peptide interacts with thymic epithelial cells and T-cell precursors to influence immune cell maturation and function.

The Zinc-Thymalin Complex:

Zinc StatusThymalin ActivityResearch Implication
Zinc-bound (1:1)Biologically activeFull receptor engagement
Zinc-freeInactiveNo biological function
Zinc-deficientImpaired activityModels deficiency states

Primary Immunomodulatory Pathways:

T-Cell Differentiation: Thymalin promotes maturation of immature T-cell precursors into functional T cells, enhancing CD3, CD4, and CD8 marker expression. This supports thymic education processes including self vs. non-self recognition mechanisms.

Hematopoietic Support: Research indicates effects on bone marrow precursor development and lymphoid lineage commitment, supporting stem cell niche interactions and differentiation pathway analysis.

Cytokine Modulation: The peptide influences production of IL-2, IL-6, and other immunomodulatory cytokines, supporting balanced Th1/Th2 responses and potential regulatory effects on inflammatory processes.

Age-Related Immune Context: Thymalin research addresses thymic involution—age-related decrease in thymic function correlating with reduced circulating thymic peptides and T-cell dysfunction (immunosenescence).

Comparative Profile:

PropertyThymalinThymosin Alpha-1Thymulin (FTS)
StructureNonapeptide28 amino acidsNonapeptide
Zinc RequirementEssentialNoneEssential
Primary TargetT-cell differentiationT-cells, DCs, NK cellsT-cell maturation
MechanismThymic hormone pathwayTLR2/TLR9 activationThymic hormone pathway
Clinical DataLimited (preclinical)Extensive (approved)Limited (preclinical)

RESEARCH APPLICATIONS

Hematopoietic Stem Cell Research: Investigation of bone marrow precursor development, lymphoid lineage commitment, stem cell niche interactions, and differentiation pathway mechanisms in controlled laboratory models.

T-Cell Differentiation Studies: Analysis of E-rosette formation, CD marker expression patterns, thymic selection processes, and T-cell receptor development in experimental systems.

Immunomodulation Research: Studies on immune response balancing, regulatory T-cell function, cytokine network modulation, and immune tolerance mechanisms in cell culture and animal models.

Immunosenescence Models: Investigation of age-related immune decline including thymic involution, T-cell repertoire restoration, age-related immune dysfunction, and zinc-thymalin interactions in aging research.

Circadian Rhythm Studies: Research examining diurnal immune variation, neuroendocrine-immune interactions, and timing-dependent immune responses mediated by thymic peptide fluctuations.

Inflammation Research: Preclinical evaluation in acute and chronic inflammation models, including inflammatory cytokine modulation and tissue-specific immune response analysis.

Tumor Immunology: Studies on tumor immune surveillance, anti-tumor immune responses, and immune checkpoint interactions in tumor-bearing animal models.

ANALYTICAL VERIFICATION

BIONIX Thymalin undergoes comprehensive analytical characterization:

• HPLC Analysis: ≥99% purity confirmation via optimized chromatographic separation
• Mass Spectrometry: Identity verification and molecular weight confirmation (858.9 Da)
• Amino Acid Analysis: Sequence confirmation (Pyr-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn)
• Endotoxin Testing: Laboratory quality assurance

Physical Characteristics:

PropertySpecification
AppearanceWhite to off-white lyophilized powder
Molecular Weight858.9 Da
SequencePyr-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn
N-TerminusPyroglutamic acid (Pyr)
Purity≥99% (HPLC-verified)

DEVELOPMENT STATUS

Thymalin remains a preclinical research compound:

• Regulatory Status: Not FDA or EMA approved
• Historical Use: Some Eastern European countries (non-Western markets)
• Clinical Stage: No registered therapeutic trials in major Western regulatory systems
• Research Applications: Preclinical immunology, mechanistic studies
• Availability: Laboratory research only

Thymalin is intended exclusively for laboratory research purposes.

FREQUENTLY ENCOUNTERED INQUIRIES

What is the zinc dependency of Thymalin?
Thymalin demonstrates absolute zinc dependence for biological activity. The peptide forms a 1:1 complex with Zn²⁺, and only the zinc-bound configuration exhibits receptor engagement and immunomodulatory function. Researchers must ensure appropriate zinc availability in experimental systems or specifically study zinc-free conditions to model deficiency states.

How does Thymalin relate to thymulin?
Thymalin is structurally related to thymulin (formerly Facteur Thymique Sérique or FTS), sharing the nonapeptide structure and zinc dependency. Both represent thymic hormones involved in T-cell development. While functionally similar, distinct receptor interactions may exist, supporting complementary research applications.

What are the primary research applications?
T-cell differentiation studies, hematopoietic stem cell research, immunosenescence models, zinc-immune interaction studies, cytokine modulation research, circadian immune rhythm investigations, and tumor immunology studies. All applications limited to controlled laboratory environments.

How should Thymalin be stored?
Lyophilized powder requires -20°C storage for long-term stability. Post-reconstitution, store at 2-8°C and use within 7-14 days. For extended storage of reconstituted solution, prepare aliquots and freeze at -20°C, avoiding repeated freeze-thaw cycles.

What differentiates Thymalin from Thymosin Alpha-1?
Thymalin is a 9-amino-acid zinc-dependent nonapeptide, while Thymosin Alpha-1 contains 28 amino acids and operates via TLR2/TLR9 activation without zinc requirement. Thymosin Alpha-1 has extensive clinical approval (35+ countries), whereas Thymalin remains in preclinical research status.

Is Thymalin approved for therapeutic use?
Negative. Thymalin is not FDA or EMA approved. It has limited historical use in some Eastern European regions but lacks regulatory approval in major Western markets. This product is intended exclusively for laboratory research.

Additional information
Dosage10mg, 20mg, 40mg, 50mg, 5mg
Product safety

Product safety

Safety instructions

SAFETY DATA SHEET (SDS)

Thymalin 20mg – Research-Grade Lyophilized Powder (RUO)

CAS Number: 63958-90-7
Synonyms: Thymalin
REACH Registration: Exempt (<1 tonne/year; Research Use Only)

SECTION 1 — Identification

1.1 Product Identifier: Thymalin 20mg – Lyophilized Powder

1.2 Identified Uses: Analytical-grade peptide for in-vitro laboratory research. Research Use Only (RUO). Not for human or veterinary use.

1.3 Supplier: BIONIX RESEARCH
Email: info@bionixresearch.com

1.4 Emergency: EU Emergency Number: 112

SECTION 2 — Hazards Identification

2.1 Classification: Not classified as hazardous under CLP Regulation (EC) 1272/2008. No GHS pictograms required.

2.2 Precautionary notes:

  • Avoid dust inhalation
  • Avoid contact with eyes
  • Laboratory use only

SECTION 3 — Composition

Substance: Thymalin 20mg
CAS: 63958-90-7
Purity: ≥99% HPLC
Form: Lyophilized powder
Impurities: None classified as hazardous.

SECTION 4 — First-Aid Measures

Inhalation: Move to fresh air. Rinse mouth and nose.

Skin Contact: Wash thoroughly with water and soap.

Eye Contact: Rinse cautiously with clean water for several minutes.

Ingestion: Rinse mouth. Do not induce vomiting. Seek medical advice.

SECTION 5 — Fire-Fighting Measures

Extinguishing Media: CO₂, dry chemical, foam, or water spray.

Hazards: Organic peptide powder, non-flammable. Thermal decomposition may release CO, CO₂, nitrogen oxides.

SECTION 6 — Accidental Release Measures

Avoid dust formation. Use gloves, mask, protective eyewear. Collect powder into sealed waste container.

SECTION 7 — Handling and Storage

Handling: Use only in laboratory settings. Minimize dust formation. Wear standard PPE.

Storage: Store at −20 °C in sealed vial. Protect from sunlight and humidity. Research use only.

SECTION 8 — Exposure Controls / Personal Protection

Exposure Limits: None established.

PPE: Nitrile or latex gloves, lab coat, protective eyewear, dust mask when handling powders.

SECTION 9 — Physical and Chemical Properties

Appearance: White to off-white lyophilized powder
Odor: None
Solubility: Soluble in sterile water, dilute acids, or aqueous buffers
Stability: Stable when stored at −20 °C

SECTION 10 — Stability and Reactivity

Stable under recommended conditions. Avoid heat, moisture, air exposure, oxidizing agents.

SECTION 11 — Toxicological Information

No data available for human exposure. Low acute toxicity expected. Dust may cause mild irritation. Not intended for injection, ingestion, or topical use.

SECTION 12 — Ecological Information

No data available. Not expected to present environmental risks. Prevent release into water systems.

SECTION 13 — Disposal Considerations

Dispose according to local regulations for laboratory chemical waste. Do not dispose via household waste or sewer systems.

SECTION 14 — Transport Information

Not regulated under ADR, IMDG, IATA. No UN classification required.

SECTION 15 — Regulatory Information

Not subject to REACH registration (<1 tonne/year; RUO exemption). Not classified under CLP. Not a pharmaceutical, cosmetic, or medical product.

SECTION 16 — Other Information

This SDS is intended for trained laboratory personnel. It does not signify suitability for therapeutic, diagnostic, or consumer applications.

Storage

STORAGE AND HANDLING

Lyophilized Peptide Stability

All BIONIX Research products are manufactured using lyophilization — a pharmaceutical-industry freeze-drying process that creates a stable crystalline structure, removing approximately 95% of moisture from the peptide compound.

This technology ensures up to 3-4 months of stability at ambient temperatures during shipping and storage. The result: a pure, puffy white powder that maintains structural integrity until reconstitution, regardless of logistical conditions.

ConditionDuration
-20°CUp to 24 months
2-8°CUp to 3 months (short-term)

Protect from light and moisture. The lyophilized state prevents hydrolytic degradation and maintains peptide bond integrity.

Reconstitution Protocol:

  • Solvent: Sterile bacteriostatic water or appropriate buffer
  • Technique: Add solvent slowly along vial wall
  • Mixing: Gently swirl until dissolved—do not shake or vortex (shear forces damage peptide bonds)
  • Sterility: Maintain aseptic conditions throughout

Post-Reconstitution Storage: 

  • 2-8°C: Use within 4 weeks
  • Aliquot and freeze at -20°C for extended storage
  • Avoid repeated freeze-thaw cycles
  • Protect from light and moisture

The 3-Tier Storage Protocol

STABLE - Prewritten Phase (Up to 4 Months) Unreconstituted lyophilized peptides remain chemically stable at room temperature (15-25°C) for 3-4 months when stored away from direct sunlight and moisture. The sealed vacuum packaging provides oxidative protection during this window.

FRESH - Active Phase (Up to 30 Days) Once reconstituted with bacteriostatic water, immediate refrigeration at 2-8°C is required. Stability degrades rapidly above this threshold — refrigerate within 30 minutes of reconstitution for optimal preservation.

PRESERVATION - Long-Term Phase (6-12 Months+) For extended storage beyond 30 days, transfer to -20°C (standard freezer, not frost-free). At this temperature, most reconstituted peptides maintain stability for 6-12 months. Note: Avoid freeze-thaw cycles — each temperature fluctuation degrades peptide bonds.

Quality Indicators to Monitor

  • Visual inspection: Solution should remain clear; cloudiness indicates degradation
  • Precipitation: Particulates signal protein denaturation — discard immediately
  • Temperature logs: Use a calibrated thermometer; refrigerator door storage fluctuates more than back shelves
  • Time tracking: Label each vial with reconstitution date — 30-day countdown begins at mixing

Handling Best Practices

Store peptides in their original amber vials until reconstitution. Post-reconstitution: dark glass, light-blocking storage containers recommended. Never expose vials to direct sunlight or UV light — photodegradation occurs within hours.

For detailed Complete Peptide Storage Protocol access our Guide. Complete Peptide Storage Protocol

Legal Notice

This product is intended exclusively for laboratory research. Not approved for human use, not for therapeutic applications, and not for in vivo studies in humans.

The buyer confirms that this product will be used exclusively for research purposes in an appropriate laboratory environment.